GSK Flu Vaccine - Search News

GSK, mRNA

Reuters on MSN · 9d

British drugmaker GSK moves mRNA flu vaccine to late-stage trials

(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, and said it would now progress to late-stage clinical development.

Bloomberg on MSN · 10d

GSK Says mRNA Flu Shot Shows Promise in Boost for Pipeline

GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage trial, keeping the drugmaker in the race to bring the technology to seasonal influenza shots.

FierceBiotech · 10d

GSK's mRNA flu vaccine finally overcomes tricky B strains in phase 2 trial

After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has

Seeking Alpha on MSN · 10d

GSK, CureVac mRNA flu shot reaches late-stage studies

GSK (NYSE:GSK) on Thursday announced its decision to advance its messenger-RNA-based flu vaccine candidate developed with CureVac (NASDAQ:CVAC) into late-stage development following a positive Phase 2 readout. The British drugmaker said that the vaccine ...

GSK’s mRNA seasonal flu vaccine shows promise in younger and older adults

GSK has shared positive headline results for its mRNA seasonal influenza vaccine and outlined that it will now progress the programme into late-stage clinical development. The phase 2 NCT06431607 study has been evaluating different dose levels of a modified,

EuropaWire · 10d

GSK’s mRNA Flu Vaccine Candidate Moves to Phase III After Positive Phase II Results

GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses again

5 Late-Stage mRNA Vaccines to Watch

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the market for cancer, influenza and more.

FDA approves an at-home flu vaccine

USA Today · 2d

FDA approves ‘FluMist,' says no healthcare provider needed

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the regulator said.

The Washington Post on MSN · 1d

FDA approves first nasal spray flu vaccine for use at home

The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year. Health experts say the convenience of the spray — FluMist — could lead to increased flu vaccination rates.

Seattle Times · 1d

Nasal flu vaccine is approved for at-home use

The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.

10d

GSK Announces Promising Data From Phase II Seasonal Influenza MRNA Vaccine Program

Thursday announced positive data from a phase II trial for its mRNA seasonal influenza vaccine programme. The study ...

The Pharma Letter9d

GSK presents positive mRNA seasonal influenza vaccine data

GSK announced positive Phase II results for its mRNA seasonal influenza vaccine, showing strong immune responses against ...

Health Affairs2d

How Policy Makers Can Act Now To Prevent An Avian Influenza Pandemic

It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

PipelineReview.com10d

GSK announces positive headline data from phase II seasonal influenza mRNA vaccine programme

LONDON, UK I 12, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results of a phase II trial (NCT06431607) for its mRNA seasonal ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results